$JAZZ Company News Speculators live by the swo
Post# of 144168
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
Speculators live by the sword, die by the sword 3:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 2:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 8:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 10:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 11:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 2:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 12:56 p.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 8:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 9:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 12:09 p.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 10:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 11:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 11:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 12:07 p.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 12:11 p.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 6:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 11:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 12:15 p.m. Sept. 17, 2012 - Val Brickates Kennedy
Meda buys women's-health portfolio in US for $95M 2:56 a.m. Sept. 6, 2012 - MarketWatch.com
Jazz Pharmaceuticals Is Taking Two Routes To Growth 5:10 p.m. Aug. 15, 2014 - Investors Business Daily
3 Health Care Stocks Pushing The Sector Higher 1:03 p.m. Aug. 15, 2014 - TheStreet.com
Insider Trading Alert - JAZZ, ATRO And RHI Traded By Insiders 11:45 a.m. Aug. 15, 2014 - TheStreet.com
Jazz Pharmaceuticals (JAZZ) Is Today's Momo Momentum Stock 9:51 a.m. Aug. 15, 2014 - TheStreet.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% - Tale of the Tape 8:44 a.m. Aug. 14, 2014 - Zacks.com
Watch Out: Barbarians At The Gate For Jazz Pharmaceuticals (JAZZ) 3:55 p.m. Aug. 13, 2014 - TheStreet.com
Jazz Pharmaceuticals PLC Stock Upgraded (JAZZ) 11:12 a.m. Aug. 13, 2014 - TheStreet.com
Why Jazz Pharmaceuticals (JAZZ) Could Be an Impressive Growth Stock - Tale of the Tape 8:44 a.m. Aug. 12, 2014 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 1:04 p.m. Aug. 11, 2014 - TheStreet.com
12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha
Perilous Reversal Stock: Jazz Pharmaceuticals (JAZZ) 2:51 p.m. Aug. 7, 2014 - TheStreet.com
Jazz Pharmaceuticals (JAZZ) Jumps: Stock Moves 5.2% Higher - Tale of the Tape 9:46 a.m. Aug. 7, 2014 - Zacks.com
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 7, 2014 - Zacks.com
Jazz Pharma Jumps After Q2 Earnings Rebound 12:36 p.m. Aug. 6, 2014 - Investors Business Daily
Barbarian At The Gate: Jazz Pharmaceuticals (JAZZ) 10:13 a.m. Aug. 6, 2014 - TheStreet.com
Earnings Up at Jazz Pharmaceuticals, Revenue Guidance Raised - Analyst Blog 9:30 a.m. Aug. 6, 2014 - Zacks.com
Jazz Pharmaceuticals Spikes In #PreMarket On Q2 Beat; Boosts Revenue Outlook 8:33 a.m. Aug. 6, 2014 - benzinga.com
Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q2 2014 Results - Earnings Call Transcript 11:58 p.m. Aug. 5, 2014 - Seeking Alpha
4 Top-Rated Drugmakers Beat Q2 Earnings Estimates 5:30 p.m. Aug. 5, 2014 - Investors Business Daily
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 9:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 9:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 6:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 4:05 p.m. Aug. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13 4:10 p.m. Aug. 4, 2014 - PR Newswire - PRF
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 9:00 a.m. July 30, 2014 - PR Newswire - PRF
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China 11:34 a.m. July 28, 2014 - BusinessWire - BZX
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China 8:02 a.m. July 28, 2014 - BusinessWire - BZX
Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma 8:40 a.m. July 23, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 4:05 p.m. July 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386 4:05 p.m. July 21, 2014 - BusinessWire - BZX
Critical Alerts For GoPro, Canadian Solar, Questcor Pharmaceuticals, Caesars Entertainment, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 8, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 8:00 a.m. July 2, 2014 - PR Newswire - PRF
Pharmaceuticals Stocks Technical Momentum -- Research on Jazz Pharma, Omeros, Pernix Therapeutics Holdings, and Salix Pharma 7:10 a.m. June 16, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Presents JZP-110 Phase 2b Data For The Treatment Of EDS Symptoms In Adults With Narcolepsy 2:40 p.m. June 2, 2014 - PR Newswire - PRF
Appointment, Investor Conferences, and Expanded Healthcare Services - Analyst Notes on Jazz Pharmaceuticals, Zoetis, Community Health Systems, Tenet and Stryker 5:00 a.m. May 28, 2014 - PR Newswire - PRF
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)